{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:30:54Z","timestamp":1793647854433,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T00:00:00Z","timestamp":1573430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Standardized Nucleic Acid Quantification for SEQuencing (SNAQ-SEQ) is a novel method that utilizes synthetic DNA internal standards spiked into each sample prior to next generation sequencing (NGS) library preparation. This method was applied to analysis of normal appearing airway epithelial cells (AEC) obtained by bronchoscopy in an effort to define a somatic mutation field effect associated with lung cancer risk. There is a need for biomarkers that reliably detect those at highest lung cancer risk, thereby enabling more effective screening by annual low dose CT. The purpose of this study was to test the hypothesis that lung cancer risk is characterized by increased prevalence of low variant allele frequency (VAF) somatic mutations in lung cancer driver genes in AEC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Synthetic DNA internal standards (IS) were prepared for 11 lung cancer driver genes and mixed with each AEC genomic (g) DNA specimen prior to competitive multiplex PCR amplicon NGS library preparation. A custom Perl script was developed to separate IS reads and respective specimen gDNA reads from each target into separate files for parallel variant frequency analysis. This approach identified nucleotide-specific sequencing error and enabled reliable detection of specimen mutations with VAF as low as 5\u2009\u00d7\u200910<jats:sup>\u2212\u20094<\/jats:sup>(0.05%). This method was applied in a retrospective case-control study of AEC specimens collected by bronchoscopic brush biopsy from the normal airways of 19 subjects, including eleven lung cancer cases and eight non-cancer controls, and the association of lung cancer risk with AEC driver gene mutations was tested.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>TP53 mutations with 0.05\u20131.0% VAF were more prevalent (<jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.05) and also enriched for tobacco smoke and age-associated mutation signatures in normal AEC from lung cancer cases compared to non-cancer controls matched for smoking and age. Further, PIK3CA and BRAF mutations in this VAF range were identified in AEC from cases but not controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Application of SNAQ-SEQ to measure mutations in the 0.05\u20131.0% VAF range enabled identification of an AEC somatic mutation field of injury associated with lung cancer risk. A biomarker comprising TP53, PIK3CA, and BRAF somatic mutations may better stratify individuals for optimal lung cancer screening and prevention outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-019-6313-x","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T09:03:14Z","timestamp":1573462994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Daniel J.","family":"Craig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadik A.","family":"Khuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Blomquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1192-6824","authenticated-orcid":false,"given":"James C.","family":"Willey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,11]]},"reference":[{"issue":"3","key":"6313_CR1","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.21037\/jtd.2018.03.15","volume":"10","author":"G Boloker","year":"2018","unstructured":"Boloker G, Wang C, Zhang J. Updated statistics of lung and bronchus cancer in United States (2018). J Thorac Dis. 2018;10(3):1158\u201361.","journal-title":"J Thorac Dis"},{"issue":"11","key":"6313_CR2","first-page":"1201","volume":"110","author":"HA Tindle","year":"2018","unstructured":"Tindle HA, Stevenson Duncan M, Greevy RA, Vasan RS, Kundu S, Massion PP, et al. Lifetime smoking history and risk of Lung Cancer: results from the Framingham heart study. J Natl Cancer Inst. 2018;110(11):1201\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"6313_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.7326\/0003-4819-159-6-201309170-00690","volume":"159","author":"LL Humphrey","year":"2013","unstructured":"Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US preventive services task force recommendation. Ann Intern Med. 2013;159(6):411\u201320.","journal-title":"Ann Intern Med"},{"issue":"5","key":"6313_CR4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"T National Lung Screening Trial Resea","year":"2011","unstructured":"National Lung Screening Trial Research T, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395\u2013409.","journal-title":"N Engl J Med"},{"issue":"6","key":"6313_CR5","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jnci\/95.6.470","volume":"95","author":"PB Bach","year":"2003","unstructured":"Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003;95(6):470\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"6313_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1940-6207.CAPR-08-0060","volume":"1","author":"MR Spitz","year":"2008","unstructured":"Spitz MR, Etzel CJ, Dong Q, Amos CI, Wei Q, Wu X, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008;1(4):250\u20134.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"17","key":"6313_CR7","first-page":"6350","volume":"61","author":"SP Hussain","year":"2001","unstructured":"Hussain SP, Amstad P, Raja K, Sawyer M, Hofseth L, Shields PG, et al. Mutability of p53 hotspot codons to benzo(a) pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res. 2001;61(17):6350\u20135.","journal-title":"Cancer Res"},{"issue":"6","key":"6313_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1158\/1940-6207.CAPR-08-0174","volume":"1","author":"K Steiling","year":"2008","unstructured":"Steiling K, Ryan J, Brody JS, Spira A. The field of tissue injury in the lung and airway. Cancer Prev Res (Phila). 2008;1(6):396\u2013403.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"6313_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10517-016-3561-5","volume":"162","author":"EE Kopantseva","year":"2016","unstructured":"Kandarakov OF, Kopantseva EE, Belyavsky AV. Analysis of proliferation of melanoma cells and Mesenchymal stem cells in co-culture and contribution of experimental conditions into interpretation of the results. Bull Exp Biol Med. 2016;162(1):127\u201333.","journal-title":"Bull Exp Biol Med"},{"issue":"3","key":"6313_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1056\/NEJM195701172560301","volume":"256","author":"O Auerbach","year":"1957","unstructured":"Auerbach O, Forman JB, Gere JB, Kassouny DY, Muehsam GE, Petrick TG, et al. Changes in the bronchial epithelium in relation to smoking and cancer of the lung; a report of progress. N Engl J Med. 1957;256(3):97\u2013104.","journal-title":"N Engl J Med"},{"issue":"1","key":"6313_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12885-017-3287-4","volume":"17","author":"J Yeo","year":"2017","unstructured":"Yeo J, Crawford EL, Zhang X, Khuder S, Chen T, Levin A, et al. A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells. BMC Cancer. 2017;17(1):301.","journal-title":"BMC Cancer"},{"issue":"6217","key":"6313_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.1260825","volume":"347","author":"C Tomasetti","year":"2015","unstructured":"Tomasetti C, Vogelstein B. Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science. 2015;347(6217):78\u201381.","journal-title":"Science."},{"issue":"4","key":"6313_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jech.32.4.303","volume":"32","author":"R Doll","year":"1978","unstructured":"Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978;32(4):303\u201313.","journal-title":"J Epidemiol Community Health"},{"issue":"6","key":"6313_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1164\/rccm.201806-1178OC","volume":"200","author":"H Kadara","year":"2019","unstructured":"Kadara H, Sivakumar S, Jakubek Y, San Lucas FA, Lang W, McDowell T, et al. Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung Cancer. Am J Respir Crit Care Med. 2019;200(6):742\u201350.","journal-title":"Am J Respir Crit Care Med"},{"key":"6313_CR15","unstructured":"Consortium TSMWGotS-I. Achieving reproducibility and accuracy in cancer mutation detection with whole-genome and whole-exome sequencing. Nature Biotechnology. 2019(In Press)."},{"key":"6313_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bdq.2015.08.003","volume":"5","author":"T Blomquist","year":"2015","unstructured":"Blomquist T, Crawford EL, Yeo J, Zhang X, Willey JC. Control for stochastic sampling variation and qualitative sequencing error in next generation sequencing. Biomol Detect Quantif. 2015;5:30\u20137.","journal-title":"Biomol Detect Quantif"},{"issue":"6","key":"6313_CR17","first-page":"316","volume":"30","author":"JW Dolan","year":"2012","unstructured":"Dolan JW. When should an internal standard be used? LCGC N Am. 2012;30(6):316\u201322.","journal-title":"LCGC N Am"},{"issue":"10","key":"6313_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/jms.922","volume":"40","author":"Z Takats","year":"2005","unstructured":"Takats Z, Wiseman JM, Cooks RG. Ambient mass spectrometry using desorption electrospray ionization (DESI): instrumentation, mechanisms and applications in forensics, chemistry, and biology. J Mass Spectrom. 2005;40(10):1261\u201375.","journal-title":"J Mass Spectrom"},{"issue":"11","key":"6313_CR19","doi-asserted-by":"publisher","first-page":"e79120","DOI":"10.1371\/journal.pone.0079120","volume":"8","author":"TM Blomquist","year":"2013","unstructured":"Blomquist TM, Crawford EL, Lovett JL, Yeo J, Stanoszek LM, Levin A, et al. Targeted RNA-sequencing with competitive multiplex-PCR amplicon libraries. PLoS One. 2013;8(11):e79120.","journal-title":"PLoS One"},{"issue":"1","key":"6313_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12890-018-0603-y","volume":"18","author":"J Yeo","year":"2018","unstructured":"Yeo J, Morales DA, Chen T, Crawford EL, Zhang X, Blomquist TM, et al. RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs. BMC pulmonary medicine. 2018;18(1):42.","journal-title":"BMC pulmonary medicine."},{"issue":"2","key":"6313_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, et al. Comprehensive characterization of Cancer driver genes and mutations. Cell. 2018;173(2):371\u201385 e18.","journal-title":"Cell."},{"key":"6313_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12890-016-0178-4","volume":"16","author":"EL Crawford","year":"2016","unstructured":"Crawford EL, Levin A, Safi F, Lu M, Baugh A, Zhang X, et al. Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository. BMC pulmonary medicine. 2016;16:16.","journal-title":"BMC pulmonary medicine"},{"issue":"9","key":"6313_CR23","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/nprot.2007.299","volume":"2","author":"L Zentilin","year":"2007","unstructured":"Zentilin L, Giacca M. Competitive PCR for precise nucleic acid quantification. Nat Protoc. 2007;2(9):2092\u2013104.","journal-title":"Nat Protoc"},{"issue":"20","key":"6313_CR24","doi-asserted-by":"crossref","first-page":"9961","DOI":"10.1016\/S0021-9258(18)43486-2","volume":"255","author":"TA Kunkel","year":"1980","unstructured":"Kunkel TA, Loeb LA. On the fidelity of DNA replication. The accuracy of Escherichia coli DNA polymerase I in copying natural DNA in vitro. J Biol Chem. 1980;255(20):9961\u20136.","journal-title":"J Biol Chem"},{"issue":"1","key":"6313_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr771","volume":"40","author":"M Kircher","year":"2012","unstructured":"Kircher M, Sawyer S, Meyer M. Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Res. 2012;40(1):e3.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"6313_CR26","doi-asserted-by":"publisher","first-page":"i318","DOI":"10.1093\/bioinformatics\/btq214","volume":"26","author":"V Bansal","year":"2010","unstructured":"Bansal V. A statistical method for the detection of variants from next-generation resequencing of DNA pools. Bioinformatics. 2010;26(12):i318\u201324.","journal-title":"Bioinformatics."},{"issue":"5","key":"6313_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"key":"6313_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12859-016-0976-y","volume":"17","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, D'Amore R, Ijaz UZ, Hall N, Quince C. Illumina error profiles: resolving fine-scale variation in metagenomic sequencing data. BMC Bioinformatics. 2016;17:125.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"6313_CR29","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13059-019-1659-6","volume":"20","author":"X Ma","year":"2019","unstructured":"Ma X, Shao Y, Tian L, Flasch DA, Mulder HL, Edmonson MN, et al. Analysis of error profiles in deep next-generation sequencing data. Genome Biol. 2019;20(1):50.","journal-title":"Genome Biol"},{"issue":"35","key":"6313_CR30","doi-asserted-by":"publisher","first-page":"9846","DOI":"10.1073\/pnas.1607794113","volume":"113","author":"ML Hoang","year":"2016","unstructured":"Hoang ML, Kinde I, Tomasetti C, McMahon KW, Rosenquist TA, Grollman AP, et al. Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing. Proc Natl Acad Sci U S A. 2016;113(35):9846\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"6313_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mrfmmm.2008.08.016","volume":"646","author":"H Sudo","year":"2008","unstructured":"Sudo H, Li-Sucholeiki XC, Marcelino LA, Gruhl AN, Herrero-Jimenez P, Zarbl H, et al. Fetal-juvenile origins of point mutations in the adult human tracheal-bronchial epithelium: absence of detectable effects of age, gender or smoking status. Mutat Res. 2008;646(1\u20132):25\u201340.","journal-title":"Mutat Res"},{"issue":"1\u20132","key":"6313_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mrfmmm.2005.12.008","volume":"596","author":"H Sudo","year":"2006","unstructured":"Sudo H, Li-Sucholeiki XC, Marcelino LA, Gruhl AN, Zarbl H, Willey JC, et al. Distributions of five common point mutants in the human tracheal-bronchial epithelium. Mutat Res. 2006;596(1\u20132):113\u201327.","journal-title":"Mutat Res"},{"issue":"11","key":"6313_CR33","doi-asserted-by":"publisher","first-page":"a026179","DOI":"10.1101\/cshperspect.a026179","volume":"6","author":"P Hainaut","year":"2016","unstructured":"Hainaut P, Pfeifer GP. Somatic TP53 Mutations in the Era of Genome Sequencing. Cold Spring Harb Perspect Med. 2016;6(11):a026179.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"6313_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<8::AID-PATH232>3.0.CO;2-Y","volume":"187","author":"WP Bennett","year":"1999","unstructured":"Bennett WP, Hussain SP, Vahakangas KH, Khan MA, Shields PG, Harris CC. Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer. J Pathol. 1999;187(1):8\u201318.","journal-title":"J Pathol"},{"issue":"7463","key":"6313_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500(7463):415\u201321.","journal-title":"Nature."},{"issue":"11","key":"6313_CR36","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nbt.2403","volume":"30","author":"AS Gargis","year":"2012","unstructured":"Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, et al. Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol. 2012;30(11):1033\u20136.","journal-title":"Nat Biotechnol"},{"key":"6313_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.18.00191","volume":"3","author":"D Stetson","year":"2019","unstructured":"Stetson D, Ahmed A, Xu X, Nuttall BRB, Lubinski TJ, Johnson JH, et al. Orthogonal comparison of four plasma NGS tests with tumor suggests technical factors are a major source of assay discordance. Jco Precision Oncology. 2019;3:1\u20139.","journal-title":"Jco Precision Oncology"},{"issue":"7","key":"6313_CR38","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1152\/physiolgenomics.00021.2016","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang X, Crawford EL, Blomquist TM, Khuder SA, Yeo J, Levin AM, et al. Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells. Physiol Genomics. 2016;48(7):537\u201343.","journal-title":"Physiol Genomics"},{"issue":"22","key":"6313_CR39","doi-asserted-by":"publisher","first-page":"8629","DOI":"10.1158\/0008-5472.CAN-09-1568","volume":"69","author":"T Blomquist","year":"2009","unstructured":"Blomquist T, Crawford EL, Mullins D, Yoon Y, Hernandez DA, Khuder S, et al. Pattern of antioxidant and DNA repair gene expression in normal airway epithelium associated with lung cancer diagnosis. Cancer Res. 2009;69(22):8629\u201335.","journal-title":"Cancer Res"},{"issue":"12","key":"6313_CR40","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/carcin\/bgm214","volume":"28","author":"EL Crawford","year":"2007","unstructured":"Crawford EL, Blomquist T, Mullins DN, Yoon Y, Hernandez DR, Al-Bagdhadi M, et al. CEBPG regulates ERCC5\/XPG expression in human bronchial epithelial cells and this regulation is modified by E2F1\/YY1 interactions. Carcinogenesis. 2007;28(12):2552\u20139.","journal-title":"Carcinogenesis."},{"issue":"22","key":"6313_CR41","doi-asserted-by":"publisher","first-page":"10727","DOI":"10.1093\/nar\/gkw873","volume":"44","author":"M Christmann","year":"2016","unstructured":"Christmann M, Boisseau C, Kitzinger R, Berac C, Allmann S, Sommer T, et al. Adaptive upregulation of DNA repair genes following benzo(a) pyrene diol epoxide protects against cell death at the expense of mutations. Nucleic Acids Res. 2016;44(22):10727\u201343.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6313_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0014-5793(00)01291-6","volume":"470","author":"K Kannan","year":"2000","unstructured":"Kannan K, Amariglio N, Rechavi G, Givol D. Profile of gene expression regulated by induced p53: connection to the TGF-beta family. FEBS Lett. 2000;470(1):77\u201382.","journal-title":"FEBS Lett"},{"issue":"1","key":"6313_CR43","first-page":"67","volume":"39","author":"TJ Slaga","year":"1979","unstructured":"Slaga TJ, Bracken WJ, Gleason G, Levin W, Yagi H, Jerina DM, et al. Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a) pyrene 7,8-diol-9,10-epoxides. Cancer Res. 1979;39(1):67\u201371.","journal-title":"Cancer Res"},{"issue":"7766","key":"6313_CR44","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-019-1330-0","volume":"571","author":"C Mascaux","year":"2019","unstructured":"Mascaux C, Angelova M, Vasaturo A, Beane J, Hijazi K, Anthoine G, et al. Immune evasion before tumour invasion in early lung squamous carcinogenesis. Nature. 2019;571(7766):570\u20135.","journal-title":"Nature."},{"issue":"6","key":"6313_CR45","first-page":"1268","volume":"58","author":"HA Coller","year":"1998","unstructured":"Coller HA, Khrapko K, Torres A, Frampton MW, Utell MJ, Thilly WG. Mutational spectra of a 100-base pair mitochondrial DNA target sequence in bronchial epithelial cells: a comparison of smoking and nonsmoking twins. Cancer Res. 1998;58(6):1268\u201377.","journal-title":"Cancer Res"},{"issue":"60","key":"6313_CR46","doi-asserted-by":"publisher","first-page":"31709","DOI":"10.18632\/oncotarget.25854","volume":"9","author":"J Rodon","year":"2018","unstructured":"Rodon J, Curigliano G, Delord JP, Harb W, Azaro A, Han Y, et al. A phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors. Oncotarget. 2018;9(60):31709\u201318.","journal-title":"Oncotarget."},{"issue":"10","key":"6313_CR47","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/S1470-2045(17)30679-4","volume":"18","author":"D Planchard","year":"2017","unstructured":"Planchard D, Smit EF, Groen HJM, Mazieres J, Besse B, Helland A, et al. Dabrafenib plus trametinib in patients with previously untreated BRAF(V600E)-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. Lancet Oncol. 2017;18(10):1307\u201316.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-6313-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-6313-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T18:09:58Z","timestamp":1612289398000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-6313-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,11]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6313"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-6313-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,11]]},"assertion":[{"value":"5 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study and the use of patient material in this study was conducted under protocols approved by the University of Toledo College of Medicine (UTCOM) Institutional Review Board, and all experiments were performed in accordance with the relevant guidelines and regulations. All subjects provided written informed consent in accordance to UTCOM Institutional Review Board protocols.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JCW has 5\u201310% equity interest in and serves as a consultant to Accugenomics, Inc. Technology relevant to this manuscript was developed and patented by JCW, TMB, and ELC and is licensed to Accugenomics. TM is the Chief Scientific Officer for Accugenomics, Inc. These relationships do not alter our adherence to all policies on sharing data and materials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1081"}}